• No se han encontrado resultados

NMR spectra chapter 5 Appendix II-D:

N/A
N/A
Protected

Academic year: 2022

Share "NMR spectra chapter 5 Appendix II-D:"

Copied!
83
0
0

Texto completo

(1)

Appendix II-D:

NMR spectra chapter 5

(2)

1.07

4.04

1.01

0.990.99

1.00

0.52 2.05 Acetone-d6

7.017.027.027.037.047.047.047.067.067.077.197.207.227.227.257.267.267.277.277.297.297.597.597.607.967.977.978.018.02

8.688.688.688.698.708.70

9.19

N-phenylpyridine-2-sulfonamide (1)

1H NMR (acetone-d6, 300 MHz)

(3)

N-(4-Methoxyphenyl)pyridine-2-sulfonamide (2)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(4)

N-(p-Tolyl)pyridine-2-sulfonamide (9)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

20.7

29.8 Acetone-d6

122.6123.5127.8130.3135.0135.9139.0

150.9

158.1

(5)

N-(4-Iodophenyl)pyridine-2-sulfonamide (10)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(6)

N-(4-Bromophenyl)pyridine-2-sulfonamide (11)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(7)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

4.13

1.02

1.031.02

1.00

0.77 2.05 Acetone-d6

7.247.267.277.287.287.297.307.317.327.617.61

7.987.998.018.048.04

8.688.688.708.70

9.33

N-(4-Chlorophenyl)pyridine-2-sulfonamide (12)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(8)

N-(4-Fluorophenyl)pyridine-2-sulfonamide (13)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(9)

19F NMR (acetone-d6, 282 MHz)

(10)

N-(4-(Trifluoromethyl)phenyl)pyridine-2-sulfonamide (3)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(11)

19F NMR (acetone-d6, 282 MHz)

(12)

Methyl 4-[N-(2-pyridyl)sulfonylamino]benzoate (14).

1H NMR (acetone-d6, 300 MHz)

(13)

N-(3-fluorophenyl)pyridine-2-sulfonamide (15)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(14)

19F NMR (acetone-d6, 471 MHz)

-200 -190 -180 -170 -160 -150 -140 -130 -120 -110 -100 -90 -80 -70 -60 -50 -40 -30 -20 -10 0

f1 (ppm)

(15)

N-(3-isopropylphenyl)pyridine-2-sulfonamide (16)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(16)

0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

N-[3-(trifluoromethyl)phenyl]pyridine-2-sulfonamide (17)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 75 MHz)

29.8 Acetone-d6

117.7117.8117.8117.9121.5121.5121.6121.6123.4124.9124.9126.7128.3131.0131.4131.8139.4139.7

151.1

157.7

(17)

19F NMR (acetone-d6, 471 MHz)

-200 -190 -180 -170 -160 -150 -140 -130 -120 -110 -100 -90 -80 -70 -60 -50 -40 -30 -20 -10 0

f1 (ppm)

(18)

1.06

1.001.021.04

1.021.04

1.00

0.93 2.05 Acetone-d6

7.057.057.067.077.527.537.797.808.048.048.048.088.09

8.698.698.708.708.708.708.718.71

9.54

N-(3-chloro-4-iodophenyl)pyridine-2-sulfonamide (18)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

29.8 Acetone-d6

91.6

121.2121.6123.4128.3

139.2139.4140.6141.5

151.1

157.6

(19)

1.07

1.001.061.03

1.031.03

1.00

0.67 2.05 Acetone-d6

7.207.217.227.227.537.537.587.598.048.048.088.08

8.698.708.708.708.708.718.718.71

9.54

N-(4-Bromo-3-chlorophenyl)pyridine-2-sulfonamide (19)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

29.8 Acetone-d6

117.2121.3122.7123.4128.3

134.9135.0139.4139.6

151.1

157.6

(20)

1.071.021.001.02

1.041.02

1.00

0.80 2.05 Acetone-d6

7.277.287.297.307.437.457.527.537.637.637.647.647.657.657.667.668.038.038.088.08

8.708.708.708.708.718.718.718.71

9.54

N-(3,4-Dichlorophenyl)pyridine-2-sulfonamide (20)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

29.8 Acetone-d6

121.3122.9123.4127.9128.3131.7132.9

139.0139.4

151.1

157.6

(21)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

4-Methyl-N-phenylbenzenesulfonamide (4)

1H NMR (acetone-d6, 300 MHz)

13C NMR (CDCl3, 75 MHz)

(22)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

N-Methyl-N-phenylpyridine-2-sulfonamide (8)

1H NMR (acetone-d6, 300 MHz)

(23)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

N-(4-Chloro-2-fluorophenyl)pyrimidine-2-sulfonamide (21-Cl)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

NHSO2Pyr Cl

F

(24)

19F NMR (acetone-d6, 282 MHz)

-40 -30 -20 -10 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190

f1 (ppm)

(25)

0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

N-(2-Bromo-4-methylphenyl)pyrimidine-2-sulfonamide (22)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220

f1 (ppm)

120 125 130 135 140 145 150 155 160 165

f1 (ppm)

(26)

N-(4-Fluorophenyl)pyrimidine-2-sulfonamide (21)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 75 MHz)

(27)

19F NMR (acetone-d6, 282 MHz)

(28)

0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

N-(p-Tolyl)pyrimidine-2-sulfonamide (23)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220

f1 (ppm)

(29)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0

f1 (ppm)

N-phenyl-2-pyridinecarboxamide (7)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220

f1 (ppm)

(30)

1.021.030.98

1.99

0.991.00

0.671.00 2.05 Acetone-d67.137.137.147.157.157.167.167.167.167.177.187.187.197.247.257.257.267.277.287.287.287.287.297.307.317.317.357.367.367.377.387.387.397.397.617.617.627.627.627.637.637.647.647.647.657.657.667.677.67

7.967.968.058.06

8.598.698.698.698.708.708.718.718.71

N-(2-Chlorophenyl)pyridine-2-sulfonamide (1-Cl)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

29.8 Acetone-d6

123.2125.9127.5127.9128.2128.5130.5135.0139.2

151.1

158.2 123.2125.9127.5127.9128.2128.5130.5

135.0

139.2

151.1

158.2

(31)

N-(2-Chloro-4-methoxyphenyl)pyridine-2-sulfonamide (2-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(32)

N-(2-Chloro-4-(trifluoromethyl)phenyl)pyridine-2-sulfonamide (3-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(33)

19F NMR (acetone-d6,282 MHz)

-40 -30 -20 -10 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190

f1 (ppm)

(34)

N-(4-chlorophenyl)-4-methylbenzenesulfonamide (4-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(35)

N-(4-chlorophenyl)-2-pyridinecarboxamide (7-Cl).

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(36)

N-Methyl-N-(4-chlorophenyl)pyridine-2-sulfonamide (8-Cl)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(37)

N-(2-Chloro-4-methylphenyl)pyridine-2-sulfonamide (9-Cl)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 125 MHz)

(38)

N-(2-Chloro-4-iodophenyl)pyridine-2-sulfonamide (10-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(39)

N-(4-Bromo-2-chlorophenyl)pyridine-2-sulfonamide (11-Cl)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 125 MHz)

(40)

1.040.932.07

1.021.05

1.000.69 2.05 Acetone-d6

7.347.357.367.367.467.477.667.667.667.677.677.677.677.687.687.687.957.977.978.078.08

8.708.708.708.708.718.718.718.718.79

N-(2,4-dichlorophenyl)pyridine-2-sulfonamide (12-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

29.8 Acetone-d6

123.2127.5128.3128.7129.2130.0131.8134.3139.4

151.1

158.1 123.2

127.5128.3128.7129.2130.0131.8134.3

139.4

151.1

158.1

(41)

N-(2-Chloro-4-fluorophenyl)pyridine-2-sulfonamide (13-Cl)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 125 MHz)

(42)

19F NMR (acetone-d6, 471 MHz)

(43)

Methyl 3-chloro-4-(pyridine-2-sulfonamido)benzoate (14-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(44)

N-(2-chloro-3-fluorophenyl)pyridine-2-sulfonamide (15-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(45)

19F NMR (acetone-d6, 471 MHz)

(46)

N-(2-chloro-5-isopropylphenyl)pyridine-2-sulfonamide (16-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(47)

-1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

N-(2-chloro-3-(trifluoromethyl)phenyl)pyridine-2-sulfonamide and N-(2-chloro-5- (trifluoromethyl)phenyl)pyridine-2-sulfonamide (17-Cl).

1H NMR (acetone-d6, 300 MHz)

NHSO2Py F3C

Cl

NHSO2Py F3C

Cl +

(48)

N-(2,3-dichloro-4-iodophenyl)pyridine-2-sulfonamide (18-Cl).

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(49)

N-(4-bromo-2,3-dichlorophenyl)pyridine-2-sulfonamide (19-Cl).

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(50)

0.95

2.06

1.041.05

1.00

0.58 2.05 Acetone-d6

7.547.577.667.667.667.677.687.687.697.707.707.728.008.018.098.10

8.698.698.718.71

8.97

N-(2,3,4-trichlorophenyl)pyridine-2-sulfonamide (20-Cl)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 125 MHz)

10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220

f1 (ppm) 125 130 135 140 145 150 155

f1 (ppm)

(51)

N-(2-Bromo-4-methoxyphenyl)pyridine-2-sulfonamide (2-Br)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 125 MHz)

(52)

N-(2-Bromo-4-methylphenyl)pyridine-2-sulfonamide (9-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(53)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

7.4 7.6 7.8 8.0 8.2 8.4 8.6

f1 (ppm)

N-(2-Bromo-4-iodophenyl)pyridine-2-sulfonamide (10-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(54)

N-(2,4-dibromophenyl)pyridine-2-sulfonamide (11-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(55)

N-(2-bromo-4-chlorophenyl)pyridine-2-sulfonamide (12-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(56)

N-(2-Bromo-4-fluorophenyl)pyridine-2-sulfonamide (13-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(57)

19F NMR (acetone-d6, 471 MHz)

(58)

N-(2-Bromo-4-(trifluoromethyl)phenyl)pyridine-2-sulfonamide (3-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(59)

19F NMR (acetone-d6, 471 MHz)

(60)

Methyl 3-bromo-4-(pyridine-2-sulfonamido)benzoate (14-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(61)

N-(2-Bromo-3-fluorophenyl)pyridine-2-sulfonamide (15-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

19F NMR (acetone-d6, 471 MHz)

(62)
(63)

N-(2-bromo-3,4-dichlorophenyl)pyridine-2-sulfonamide (20-Br)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(64)

N-(2-Iodo-4-(trifluoromethyl)phenyl)pyridine-2-sulfonamide (3-I)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(65)

19F NMR (acetone-d6, 471 MHz)

(66)

Methyl 3-iodo-4-(pyridine-2-sulfonamido)benzoate (14-I).

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(67)

-1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5

f1 (ppm)

N-(2,6-dichloro-4-fluorophenyl)pyrimidine-2-sulfonamide (21-Cl2)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 125 MHz)

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220

f1 (ppm) 120 130 140 150 160

f1 (ppm)

(68)

19F NMR (acetone-d6, 282 MHz)

-40 -30 -20 -10 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190

f1 (ppm)

(69)

N-(2-Bromo-6-chloro-4-methylphenyl)pyrimidine-2-sulfonamide (22-Cl)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(70)

N-(2,6-Dichloro-4-methylphenyl)pyrimidine-2-sulfonamide (23-Cl2)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

(71)

N-(2,6-Dichloro-4-methylphenyl)pyrimidine-2-sulfonamide (26)

1H NMR (acetone-d6, 500 MHz)

13C NMR (acetone-d6, 125 MHz)

19F NMR (acetone-d6, 471 MHz)

(72)
(73)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

2-Phenyl-5-(trifluoromethyl)-1H-indole (27)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220

f1 (ppm)

100 105 110 115 120 125 130 135 140

f1 (ppm)

(74)

N-phenylpyridine-2-sulfonamide-d1 (29)

1H NMR (acetone-d6, 300 MHz)

13C NMR (acetone-d6, 75 MHz)

(75)

1.021.030.98

1.99

0.991.00

0.671.00 2.05 Acetone-d67.137.137.147.157.157.167.167.167.167.177.187.187.197.247.257.257.267.277.287.287.287.287.297.307.317.317.357.367.367.377.387.387.397.397.617.617.627.627.627.637.637.647.647.647.657.657.667.677.67

7.967.968.058.06

8.598.698.698.698.708.708.718.718.71

INTRAMOLECULAR ISOTOPIC KINETIC EFFECT

NHSO2Py

Cl +

NHSO2Py Cl

H D

1:1

(76)

0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

7.5 8.0

8.5

f1 (ppm)

REGIOSELECTIVITY

N-(2-Chloro-4-iodophenyl)pyridine-2-sulfonamide (10-Cl)

1H NMR (acetone-d6, 500 MHz)

N-(2-Chloro-4-iodophenyl)pyridine-2-sulfonamide (30)

1H NMR (acetone-d6, 500 MHz)

(77)

0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5

f1 (ppm)

N-(2-Chloro-4-fluorophenyl)pyridine-2-sulfonamide (13-Cl):

1H NMR (acetone-d6, 500 MHz)

N-(2-Chloro-4-fluorophenyl)pyridine-2-sulfonamide (31)

1H NMR (acetone-d6, 500 MHz)

(78)

0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm)

Methyl 3-chloro-4-(pyridine-2-sulfonamido)benzoate (14-Cl)

1H NMR (acetone-d6, 500 MHz)

Methyl 3-chloro-4-(pyridine-2-sulfonamido)benzoate (32)

1H NMR (acetone-d6, 500 MHz)

(79)

1.06

1.001.021.04

1.021.04

1.00

0.93 2.05 Acetone-d6

7.057.057.067.077.527.537.797.808.048.048.048.088.09

8.698.698.708.708.708.708.718.71

9.54

N-(2-Chloro-4-iodophenyl)pyridine-2-sulfonamide (10-Cl)

1H NMR (acetone-d6, 500 MHz)

N-(3-chloro-4-iodophenyl)pyridine-2-sulfonamide (18)

1H NMR (acetone-d6, 500 MHz)

(80)

1.07

1.001.061.03

1.031.03

1.00

0.67 2.05 Acetone-d6

7.207.217.227.227.537.537.587.598.048.048.088.08

8.698.708.708.708.708.718.718.71

9.54

N-(4-Bromo-2-chlorophenyl)pyridine-2-sulfonamide (11-Cl)

1H NMR (acetone-d6, 300 MHz)

N-(4-Bromo-3-chlorophenyl)pyridine-2-sulfonamide (19)

1H NMR (acetone-d6, 500 MHz)

(81)

1.071.021.001.02

1.041.02

1.00

0.80 2.05 Acetone-d6

7.277.287.297.307.437.457.527.537.637.637.647.647.657.657.667.668.038.038.088.08

8.708.708.708.708.718.718.718.71

9.54 1.040.932.07

1.021.05

1.000.69 2.05 Acetone-d6

7.347.357.367.367.467.477.667.667.667.677.677.677.677.687.687.687.957.977.978.078.08

8.708.708.708.708.718.718.718.718.79

N-(2,4-dichlorophenyl)pyridine-2-sulfonamide (12-Cl)

1H NMR (acetone-d6, 500 MHz)

N-(3,4-Dichlorophenyl)pyridine-2-sulfonamide (20)

1H NMR (acetone-d6, 500 MHz)

(82)

0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0

f1 (ppm) 7.0 7.2 7.4 7.6 7.8 8.0 8.2 8.4 8.6 8.8

f1 (ppm)

N-(2-Chloro-4-methoxyphenyl)pyridine-2-sulfonamide (2-Cl)

1H NMR (acetone-d6, 500 MHz)

N-(3-chloro-4-methoxyphenyl)pyridine-2-sulfonamide (33)

1H NMR (acetone-d6, 500 MHz)

(83)

13C NMR (acetone-d6, 125 MHz)

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220

f1 (ppm)

115 120 125 130 135 140 145 150 155

f1 (ppm)

Referencias

Documento similar

In summary, results at the vertex level were weak: (a) correlations between cortical indices and n-back performance were observed in right superior parietal,

One of the main issues in Me-DLC research is the improvement of the mechanical performance, which depends on the metal used and the way that it incorporates into the film. The

It can be easily deduced from the MESP function that bridging oxygens are generally more basic than terminal oxygens since the regions close to terminal OMo and OW oxygen sites

 The relative strength of these lines coupled with the overall form of the spectra will allow the spectra type to be accurately determined... Some views of EMIR.. E-II:

2(b-d) show the comparison between the emission spectra collected in and out of the vicinity of the Ag NPs chain in different spectral regions. The spectra show a well

For a given metallicity, the changes in the emission-line spectrum and in the ionization parameter are due to the changes in the cluster mass, which determines the number of

Contrary to the 1 H NMR spectra recorded in organic solvents, like CDCl 2 CDCl 2 (TCE-D 2 ), the broad features observed in water indicated, however, that 1 is strongly

This chapter emphasizes the specification of fitness and epistasis, both directly (i.e., specifying the effects of individual mutations and their epistatic interactions) and